SEC Form 4 · accession 0001246360-17-001295
DENTSPLY SIRONA Inc. · XRAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ulrich Michel
Officer — Executive Vice President & CFO
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2017 | M | 16,101 | $37.54 | A | 94,067 | D | |
| Common StockF2 | Mar 8, 2017 | S | 16,101 | $62.8764 | D | 77,966 | D | |
| Common Stock | Mar 9, 2017 | M | 7,899 | $37.54 | A | 85,865 | D | |
| Common StockF3 | Mar 9, 2017 | S | 7,899 | $62.7769 | D | 77,966 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $37.54 | Mar 8, 2017 | M | 16,101 | D | — | Jul 29, 2013 | Common Stock | 16,101 | 11,676 | D |
| Employee Stock Option (Right to Buy)F1 | $37.54 | Mar 9, 2017 | S | 7,899 | D | — | Jul 29, 2013 | Common Stock | 7,899 | 3,777 | D |
Explanation of responses
- F1This option is fully vested and exercisable.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.75 to $62.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.75 to $62.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.